Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

Go back to Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.41 --0 (-0%)
Previous Close $2.41    52 Week High $7.79 
Open $2.40    52 Week Low $4.32 
Day High $2.43    P/E N/A 
Day Low $2.36    EPS $-0.36 
Volume 191,227       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.41 --0 (-0%)
Previous Close $2.41    52 Week High $7.79 
Open $2.40    52 Week Low $4.32 
Day High $2.43    P/E N/A 
Day Low $2.36    EPS $-0.36 
Volume 191,227